CASP3 and breast cancer: Interestingly, Cheng et al. studied the molecular mechanism of YM155 in various drug-resistant breast cancers, such as tamoxifen-resistant and caspase-3 deficient breast cancers, revealing IC50 values in the low nanomolar range.